Suchergebnisse - (Person:"Barreiro, Pablo")

PubPharm (8)

1

Safety considerations in the management of hepatitis C and HIV co-infection

enthalten in: Expert opinion on drug safety | 2023

von Soriano, V. | Moreno-Torres, V. | Treviño, A. | +4

2

Dual antiretroviral therapy for HIV infection

enthalten in: Expert opinion on drug safety | 2017

von Soriano, V. | Fernandez-Montero, J. | Benitez-Gutierrez, L. | +5

3

Dual antiretroviral therapy for HIV infection

enthalten in: Expert opinion on drug safety | 2017

von Soriano, V. | Fernandez-Montero, J. | Benitez-Gutierrez, L. | +5

4

Dual antiviral therapy for HIV and hepatitis C - drug interactions and side effects

enthalten in: Expert opinion on drug safety | 2015

von Esposito, I. | Labarga, P. | Barreiro, P. | +5

5

Dual antiviral therapy for HIV and hepatitis C – drug interactions and side effects

enthalten in: Expert opinion on drug safety | 2015

von Esposito, I. | Labarga, P. | Barreiro, P. | +5

6

Dual antiviral therapy for HIV and hepatitis C - drug interactions and side effects

enthalten in: Expert opinion on drug safety | 2015

von Esposito, I. | Labarga, P. | Barreiro, P. | +5

7

Antiretroviral drug-related toxicities - clinical spectrum, prevention, and management

enthalten in: Expert opinion on drug safety | 2013

von Fernandez-Montero, J. | Eugenia, E. | Barreiro, P. | +2

8

Antiretroviral drug-related toxicities - clinical spectrum, prevention, and management

enthalten in: Expert opinion on drug safety | 2013

von Fernandez-Montero, J. | Eugenia, E. | Barreiro, P. | +2

1
[1]